Adenosine a2a and a2b receptor dual antagonists for immuno-oncology
US-2023322785-A1 · Oct 12, 2023 · US
This page is not indexed by search engines while we improve data quality.
Boyce Christopher W — Human Necessities
Boyce Christopher W holds 5 patents in Human Necessities, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Boyce Christopher W |
| Technology | Human Necessities |
| Patents in slice | 5 |
| Recent patents in slice | 1 |
| First year | 2015 |
| Last year | 2023 |
Representative patents
Notable publications linking Boyce Christopher W to Human Necessities.
Adenosine a2a and a2b receptor dual antagonists for immuno-oncology
US-2023322785-A1 · Oct 12, 2023 · US
Adenosine a2a and a2b receptor dual antagonists for immuno-oncology
US-2023322785-A1 · Oct 12, 2023 · US
Adenosine a2a and a2b receptor dual antagonists for immuno-oncology
US-2023322785-A1 · Oct 12, 2023 · US
Quinoxalines and AZA-quinoxalines as CRTH2 receptor modulators
US-9469615-B2 · Oct 18, 2016 · US
Recent filings
Latest patents from Boyce Christopher W in Human Necessities.
Adenosine a2a and a2b receptor dual antagonists for immuno-oncology
US-2023322785-A1 · Oct 12, 2023 · US
Adenosine a2a and a2b receptor dual antagonists for immuno-oncology
US-2023322785-A1 · Oct 12, 2023 · US
Adenosine a2a and a2b receptor dual antagonists for immuno-oncology
US-2023322785-A1 · Oct 12, 2023 · US
Adenosine a2a and a2b receptor dual antagonists for immuno-oncology
US-2023322785-A1 · Oct 12, 2023 · US
Quinoxalines and AZA-quinoxalines as CRTH2 receptor modulators
US-9469615-B2 · Oct 18, 2016 · US
Related pages
Navigate to parent entity pages.